FAKTOR OPTIONSSCHEIN - MERCK & CO. | Market Closed - Boerse Frankfurt Warrants 18:38:48 12/06/2024 BST | ||
| 6.93 EUR | -0.29% |
|
| Current month | -12.72% | ||
| 1 month | -2.53% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 12/06/24 | 6.93 | -0.29% |
| 11/06/24 | 6.95 | -0.71% |
| 10/06/24 | 7 | +0.14% |
| 07/06/24 | 6.99 | -1.27% |
| 06/06/24 | 7.08 | -0.56% |
Real-time Boerse Frankfurt Warrants
Last update June 12, 2024 at 06:38 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UM1T1K |
| ISIN | DE000UM1T1K2 |
| Date issued | 20/02/2024 |
| Strike | 175.8 $ |
| Maturity | Unlimited |
| Parity | 5.93 : 1 |
| Emission price | 7.9 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.19 € |
|---|---|
| Lowest since issue | 6.66 € |
| Spread | 0.1 € |
| Spread % | 1.40% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.2
USD
Average target price
142.7
USD
Spread / Average Target
+9.59%
- Stock Market
- Certificates
- Certificat
